Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vaginal Neoplasms × Chemoradiotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Lung Neoplasms 3 Glioblastoma 2 Vaginal Neoplasms 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Rectal Neoplasms 1 Radiation Injuries 1 Ototoxicity 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphatic Metastasis 1 Locally Advanced Cervical Cancer 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hearing Loss 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Cognitive Dysfunction 1 Cholangiocarcinoma 1 Cardiovascular Diseases 1 Cardiotoxicity 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adult Patients With Locally Advanced Rectal Cancer Indicated to Neoadjuvant Therapy and Surgery 1

Interventions

Surveys and Questionnaires 4 trastuzumab deruxtecan 1 X-Rays 1 Surgical Procedures, Operative 1 Psychiatric Rehabilitation 1 Observation 1 Magnetic Resonance Spectroscopy 1 Hysterectomy 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Hematologic Tests 1 Chemoradiotherapy 1 CA-125 Antigen 1 Buthionine Sulfoximine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06314568 2025-08-15

TRIDENT

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Vaginal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡